Download Citation
Article Source:
Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates with Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia
Gleason RL Jr,
Caulk AW,
Seifu D,
Parker I,
Vidakovic B,
et al.
(2015)
Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates with Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia.
PLOS ONE 10(4): e0117125.
https://doi.org/10.1371/journal.pone.0117125